تداخل‌های دارویی
Insulin degludec-insulin aspart + Pioglitazone
شدت: شدید
Insulin degludec-insulin aspart and Pioglitazone: major interaction.
آخرین به‌روزرسانی
ویژه کادر درمان — فقط جهت مرجع. این صفحه خلاصه‌ای کوتاه است، توصیه پزشکی نیست و جایگزین بروشور رسمی یا قضاوت بالینی نمی‌شود. پیش از تجویز یا تحویل دارو همیشه بررسی کنید.
محتوای بالینی این صفحه فقط به زبان انگلیسی موجود است.
خلاصه
Pioglitazone combined with insulin gives additive glucose lowering and increases the risk of hypoglycemia. The combination also raises the risk of fluid retention, edema and heart failure.
معنای این تداخل به زبان ساده
Insulin degludec-insulin aspart and Pioglitazone can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Insulin degludec-insulin aspart belongs to Endocrine; Pioglitazone belongs to Endocrine.
چرا رخ می‌دهد
Pioglitazone improves insulin sensitivity, adding to insulin effect; it also promotes sodium and fluid retention.
اقدام لازم
Consider reducing the insulin dose when pioglitazone is started and monitor glucose. Watch for weight gain, edema and heart failure symptoms.
از داروساز چه بپرسید
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
ویژه اعضای Pro+
باز کردن کل صفحه
یک حساب بسازید و دوره آزمایشی Pro+ را شروع کنید تا توصیه‌های کامل مدیریت Insulin degludec-insulin aspart و Pioglitazone، یادداشت‌های تکمیلی، جزئیات شواهد و بررسی‌کننده تداخل برای کل نسخه را باز کنید.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Pro+ را ۱۴ روز رایگان در وب امتحان کنید. بدون نیاز به کارت.
تداخلات دیگر Insulin degludec-insulin aspart
تداخلات دیگر Pioglitazone
پرسش‌های متداول
Can I take Insulin degludec-insulin aspart with Pioglitazone?
MediHelp rates the interaction as major. Insulin degludec-insulin aspart and Pioglitazone can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Pioglitazone combined with insulin gives additive glucose lowering and increases the risk of hypoglycemia. The combination also raises the risk of fluid retention, edema and heart failure.
How serious is the interaction between Insulin degludec-insulin aspart and Pioglitazone?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Consider reducing the insulin dose when pioglitazone is started and monitor glucose. Watch for weight gain, edema and heart failure symptoms.
What other medicines interact with Insulin degludec-insulin aspart?
MediHelp also lists interactions of Insulin degludec-insulin aspart with, for example, Chlorpropamide, Clozapine, Diazoxide. The full list is on the Insulin degludec-insulin aspart page.
تک‌نگاری کامل، دوزاژ و بررسی تداخل دارویی در برنامه MediHelp
مرجع کامل را باز کنید، تداخل چند دارو را بررسی کنید و از ابزارهای دوز در برنامه MediHelp استفاده کنید.
